ZigiOps · Exalate · Unito · BMC Helix iPaaS
Zachary Fouts · 2026-04-30
Note: This deck accompanies the written due-diligence document. Audience is technical decision-makers and procurement reviewers. The goal is a balanced comparison of four BMC Remedy integration options, with claims tagged by verification source.
This analysis is independent research based exclusively on publicly available sources.
No conversations, briefings, demos, or NDA-protected materials have been exchanged with any of the four vendors evaluated.
This research was not commissioned, sponsored, or reviewed by any vendor.
Vendor offerings, pricing, and compliance posture in actual procurement may differ from the public record; all findings should be confirmed with the vendor directly before signing.
Note: For a public comparison document, the source-of-truth boundary matters. Calling it out up front avoids any reader assumption that this reflects vendor-supplied information or paid analyst access.
> “Which platform should we use to build a bi-directional integration between Atlassian Jira and BMC Remedy?”
Four candidate vendors on the market.
This deck compares them on the same axes: native Jira ↔ Remedy connector availability, architecture, security posture, pricing, and analyst placement.
Note: Scope is bi-directional Jira ↔ BMC Remedy / Helix ITSM. Other endpoints (ServiceNow, Salesforce, Azure DevOps, monitoring tools) appear in vendor capability context but are not the primary integration target. The output is a comparison, not a pitch.
Note: The headline finding — that two of three third-party vendors do not support BMC Remedy — collapses the shortlist to two. Beyond that, the choice between ZigiOps and BMC Helix iPaaS depends on scope, budget, and integration roadmap.
| ZigiOps | Exalate | Unito | BMC iPaaS | |
|---|---|---|---|---|
| Native Jira ↔ Remedy connector | ✅ | ❌ | ❌ | ✅ |
| Atlassian Marketplace presence | Stale (2022) | Gold Partner | Listed | N/A |
| BMC partner status | Self-described | None | None | OEM |
| On-prem option | ✅ | Partial | ❌ | ✅ |
| Pricing transparency | Quote | Public | Public | Quote |
| Shortlist status | Qualified | Excluded | Excluded | Qualified |
[VERIFIED] — confirmed against first-party vendor page, docs, or marketplace listing.
[VENDOR CLAIM] — stated in marketing; not independently corroborated.
[BIASED SOURCE] — sourced from a competitor’s comparison page. Corroborative only.
[UNVERIFIED] — could not confirm from any reliable public source. Flagged, not asserted.
Verification conducted against vendor sites, product documentation, marketplace listings, authoritative registries, analyst placements, customer-review platforms, and Wayback Machine snapshots.
No vendor was contacted in the course of this research.
Note: Every factual claim in the written doc carries one of these four tags. A diligence document that claims to have verified everything is not credible. Marking our uncertainty is the rigor.
Point-to-point sync tools — ZigiOps, Exalate, Unito
Integration Platform as a Service (iPaaS) — BMC Helix iPaaS
Different categories. Different price points. Different decisions.
Exalate does not ship a native BMC Remedy connector.
Three signals confirm it.
Exalate’s own integrations page and supported-connectors documentation list no BMC product.
[VERIFIED 2026-04-22]
Exalate’s own community forum. A user asked:
> “Any plans to integrate with BMC Remedy?”
Response from Francis Martens, Exalate CEO and co-founder (2020-08-14):
> “This is possible as a custom project — please contact our sales directly for more details.”
[VERIFIED] via https://community.exalate.com/t/any-plans-to-integrate-with-bmc-remedy/4313 · the post is over five years old and is the most recent public statement.
No roadmap commitment. The vendor’s own public guidance is: it’s a custom build.
Exalate’s own competitive comparison with ZigiOps credits ZigiOps with BMC Helix/Remedy support.
It does not claim equivalent coverage for itself.
[VERIFIED] via exalate.com/blog/zigiops · [BIASED SOURCE — used only to corroborate]
Three paths. None are a product purchase.
All three reduce to bespoke engineering.
[VERIFIED][UNVERIFIED][VERIFIED][VERIFIED]Note: Exalate is a competent product in its actual market — cross-company Jira integration with asymmetric trust boundaries. It is not the product this requirement calls for.
Unito does not ship a native BMC Remedy connector.
Verified on 2026-04-22 against Unito’s own 67-connector catalog.
| Source | Finding |
|---|---|
| unito.io/connectors/ | 67 connectors. Zero BMC products. |
| unito.io/integrations/ | No BMC. No “upcoming” BMC. |
| guide.unito.io/integration-documentation | No BMC docs exist. |
| bmc.com/partners/bmc-integrations.html | Unito not listed. |
Unito is not a BMC partner.
Positioning: “No-code, 2-way sync in minutes” for cross-SaaS work-management
Strengths:
Not positioned as an enterprise ITSM integrator.
Deployment: SaaS only. AWS US only. No self-hosted, no on-prem, no EU residency.
| Plan | Price | Update frequency | Gating |
|---|---|---|---|
| Basic | $99/mo | 15-min polling | Single-hub constraint |
| Pro | $299/mo | 15-min polling | Custom fields |
| Business | $769/mo | Real-time | Any-to-any |
| Enterprise | Custom | Real-time | SSO, premium connectors |
Real-time sync is gated at $769/mo. SSO, Salesforce, ServiceNow, and on-prem connectors are Enterprise-only.
Note: The dispositive finding is the absence of a native connector. The 15-minute polling delays, hub-tool constraints, and Enterprise-only premium connectors are operational gaps that would matter if Unito offered BMC Remedy at all — but it does not.
What it is: Jitterbit Harmony, sold and supported by BMC, with BMC-authored Helix connectors and templates.
Relationship: OEM partnership announced July 27, 2021. Same runtime as standard Jitterbit Harmony — Cloud Studio, Jitterscript, API Manager.
Accountability: BMC is the contract party, first-line support, and roadmap owner for BMC-specific content.
Cloud Agents — managed by Jitterbit; cloud-to-cloud integrations.
Private Agents — customer-deployed inside the firewall. Outbound-only to Harmony. Required pattern for on-prem BMC Remedy. Clusterable for HA.
Data residency — NA, EMEA, APAC regions.
First-class objects (per Jitterbit connector docs):
[VENDOR CLAIM]Documented OOTB templates (BMC docs):
Other templates (Azure DevOps, Discovery↔CMDB, Teams/Slack) are referenced in marketing but not enumerated in BMC’s current OOTB-templates documentation.
[UNVERIFIED]. Confirm at procurement.Note: A balanced comparison includes the cons. Reader should weigh against the pros for the specific scope, budget, and roadmap.
Company: ZigiWave · Sofia, Bulgaria · founded 2019 · ~28-31 total employees · ISO 27001:2013 certified (transition to 2022 revision unconfirmed)
BMC partner status: Self-described BMC partner; no Technology Alliance tier confirmed
Deployment: On-prem (Windows/Linux), SaaS (AWS), or customer-managed cloud
Architecture: Agentless, stateless, zero-data-retention for payloads
Note: ZigiOps is the only third-party vendor of the three that ships a productized BMC Remedy connector. This is confirmed by their own docs and the OpenText ITOM Marketplace listing for “ZigiOps for BMC Remedy” at the Partner-content tier. The Atlassian Marketplace BMC Remedy listing (app 1221587) was last updated 2022-08-02 and carries no Marketplace Partner tier badge — a supplier-risk signal.
Supported objects:
[VERIFIED][VERIFIED][VERIFIED / VENDOR CLAIM][VENDOR CLAIM][VENDOR CLAIM][VERIFIED][VENDOR CLAIM]Attachments, work notes, comments: bi-directional [VERIFIED]
Version matrix for Remedy/Helix: not publicly published [UNVERIFIED]
[UNVERIFIED]| ZigiOps | Exalate | Unito | BMC iPaaS | |
|---|---|---|---|---|
| Native BMC connector | ✅ | ❌ | ❌ | ✅ |
| Config approach | No-code + JS | Groovy + AI | No-code | Low-code + Jitterscript |
| Deployment | Cloud/on-prem | Cloud/DC nodes | SaaS only | Cloud/Private Agents |
| API Management | — | — | — | Full suite |
| Real-time sync | ✅ | ✅ | $769/mo tier | ✅ |
| CMDB first-class | Vendor claim (Atrium) | — | — | ✅ |
| ZigiOps | Exalate | Unito | BMC iPaaS | |
|---|---|---|---|---|
| ISO 27001 | ✅ | ✅ | ❓ | ✅ |
| SOC 2 Type II | ❓ | ❓ | ✅ | ✅ |
| HIPAA BAA | ❓ | ❓ | ❓ | ✅ (eligible tiers) |
| FedRAMP | ❌ | ❌ | ❌ | BMC Helix Moderate ATO since 2016-05-05 |
| Data residency | On-prem or SaaS | EU/US clusters | US only | Multi-region |
| SSO | SAML 2.0 | Limited public docs | Enterprise tier only | SAML / OIDC |
| ZigiOps | Exalate | Unito | BMC iPaaS | |
|---|---|---|---|---|
| Pricing transparency | Quote | Public | Public | Quote |
| Model | Per system-pair | Per active items | Items + features | Enterprise capacity |
| Free tier | Trial + PoC | ✅ | ❌ | ❌ |
| PS engagement | Bundled | Separate | Enterprise-only | Separate (4–12 wks) |
| BMC Remedy in pricing? | ✅ | ❌ (Enterprise + custom) | ❌ (custom build) | ✅ |
| Option | Directional annual cost (enterprise scope) |
|---|---|
| Unito Basic / Pro | $1.2K – $3.6K |
| Exalate Starter / Scale | $1.2K – $3.4K |
| Unito Business | ~$9.2K |
| Exalate Pro+ | $6.6K+ |
| ZigiOps (low-five-figures per pair) | $12K – $40K |
| BMC Helix iPaaS | $30K – $250K+ |
BMC iPaaS is 3–10× more expensive than ZigiOps for narrow scope. The premium buys first-party accountability, roadmap alignment, full iPaaS capability, and FedRAMP Moderate on the BMC Helix layer. Whether that is worth it depends on the integration scope and roadmap.
Note: For broader integration roadmaps (HR-to-AD, ERP-to-CMDB, future API-led services), the same BMC iPaaS spend covers more surface area than the narrow ticket-sync purchase price suggests, narrowing the gap to ZigiOps over multi-year TCO.
| Regulatory regime | Stronger fit | One-line reason |
|---|---|---|
| Government / Federal (FedRAMP, FISMA, DoD IL, CJIS, CMMC) | Conditional | BMC Helix has FedRAMP Moderate ATO; Jitterbit not separately listed — confirm iPaaS-layer boundary |
| Financial services (SOX, FFIEC, DORA, FCA, MAS, HKMA, APRA) | BMC iPaaS | Full iPaaS scope, multi-region residency, current SOC 2 + ISO 27001 |
| Healthcare / PHI (HIPAA, HITECH, HITRUST, GDPR) | BMC iPaaS | BAA available on eligible tiers; ZigiOps does not advertise BAA |
| Life sciences / pharmaceutical (FDA 21 CFR Part 11, EMA Annex 11, GxP) | BMC iPaaS | Long validated-deployment history; CSV paths well-trodden |
| Strict data sovereignty / zero data transit / classified | ZigiOps on-prem | On-prem keeps payloads inside customer perimeter |
| Critical infrastructure (NERC CIP, TSA SD-2021-02, NIST CSF) | Conditional | Neither vendor publishes NERC CIP attestations — verify in procurement |
Federal / FedRAMP: BMC Helix has Moderate ATO since 2016-05-05. Jitterbit Harmony itself is not on the FedRAMP marketplace. Whether the iPaaS layer falls inside BMC Helix’s authorization boundary is the load-bearing procurement question for federal workloads.
Multinational financial services: DORA Articles 28–29 require Jitterbit to be declared as a critical ICT subcontractor with transitive audit rights. Jitterbit’s PE ownership, 2024 CEO change, and AI strategy pivot are material under DORA “expected service continuity” assessment. Schrems II BYOK + national data-localization (China, India) need verification.
Healthcare PHI: ZigiOps does not advertise BAA. For any workload touching HIPAA-scope PHI, BMC iPaaS is the practical choice; ZigiOps generally is not.
Strict data sovereignty: ZigiOps on-prem is the stronger choice — payloads stay in the customer perimeter. BMC’s Private Agents are outbound-only but metadata transits to Jitterbit Harmony.
Note: The full regulated-enterprise analysis (Government, Financial Services, Healthcare, Life Sciences) with regulations-in-scope, posture comparisons, and procurement caveats is in the written report.
The two qualified options serve different scopes.
BMC Helix iPaaS is the stronger fit when:
ZigiOps is the stronger fit when:
Note: Both options have legitimate use cases. The right choice depends on scope, budget, and roadmap — not on which is “the better product.”
If the organization is already running BMC Helix iPaaS for other integrations, that materially raises the bar to bring in a separate vendor for Jira ↔ Remedy. The reuse argument:
The symmetric case applies if ZigiOps is already in use for other ITSM-bridge patterns: introducing BMC iPaaS for one Jira ↔ Remedy lane fragments the integration estate.
Note: This is a real procurement consideration, not a recommendation. Existing platform investment is a legitimate decision factor but does not by itself answer the question. It tilts the scale; it does not flip a fundamentally bad fit into a good one.
For BMC iPaaS:
For ZigiOps:
ZigiOps: BMC partnership tier · SOC 2 Type II · HIPAA BAA · SaaS residency · uptime SLA · version matrix · per-pair pricing · ISO 27001:2022 transition status · 24/7 follow-the-sun support coverage
Exalate: SOC 2 Type II · admin SSO · cluster regions · throughput SLA · BMC-specific partner
Unito: ISO 27001 · HIPAA · items-in-sync caps per tier · Enterprise SLA · PS rate card
BMC iPaaS: BYOK tier · throughput benchmarks · whether iPaaS layer is inside BMC’s FedRAMP Moderate boundary
Items above are open questions for procurement, not deal-breakers.
Questions?
Full written report: /reports/jira-bmc-integration/
Note: The written report is the source of truth. This deck is a navigation aid; every claim is backed by a citation in the written doc.